Donation matching initiative bolsters pet cancer research

Industry & Associations

Blue Buffalo Will Match Pet Cancer Research Donations Up to $200,000

Blue Buffalo will match donations to Morris Animal Foundation dollar for dollar up to $200,000 through Dec. 31, 2026, backing studies from the Golden Retriever Lifetime Study to AI-driven cancer screening.

Photo: Ayla Verschueren / unsplash

Blue Buffalo will match every donation to Morris Animal Foundation dollar for dollar, up to $200,000, through December 31, 2026. The company announced the matching initiative during National Pet Cancer Awareness Month, and it extends a partnership between the pet food manufacturer and the animal health research nonprofit that has lasted nearly 20 years.

The match applies to contributions from pet owners and animal advocates made through Morris Animal Foundation, with donations matched through the end of the year subject to the $200,000 ceiling. For practices and clinics that field client questions about where research dollars go, the campaign offers a concrete answer: the foundation directs funds toward longitudinal studies, therapeutic research and diagnostic work in dogs and cats.

What does the funding support?

The partnership's most visible project is the Golden Retriever Lifetime Study, which follows thousands of dogs across their entire lives. The study has collected more than 650,000 biological samples and generated 75 million data points that scientists use to investigate cancer and other health conditions in the breed.

Beyond that cohort, partnership-funded research spans several fronts relevant to daily casework:

  • Investigations into potential treatments for canine bone cancer
  • Improved diagnostic approaches for feline inflammatory bowel disease and intestinal lymphoma
  • Work applying artificial intelligence to identify early signs of certain cancers, including lymphoma, by analyzing DNA fragments in blood samples

The AI-driven blood analysis line may hold particular interest for clinicians, because it targets the diagnostic gap that most often determines outcomes in veterinary oncology: finding disease before clinical signs advance.

Why long-term studies matter

"Understanding cancer starts with understanding how it develops, and that requires studying animals over time," says Dr. Kelly Diehl, senior director of scientific programs at Morris Animal Foundation.

That premise underpins the Golden Retriever Lifetime Study's design. Rather than sampling disease at a single point, researchers track the same animals across years, building datasets large enough — 75 million data points to date — to support statistically robust conclusions about how and when cancers emerge. The biological sample bank, now exceeding 650,000 specimens, gives investigators material for studies that the original study designers may not have anticipated.

For companion-animal medicine, the practical payoff is earlier detection and better-characterized disease trajectories. The foundation frames the goal plainly: improve understanding of cancer, support earlier detection and advance treatment options for dogs and cats.

How the money adds up

Blue Buffalo has contributed more than $9 million to animal health research through the foundation over the course of the partnership. The current campaign adds a matching mechanism on top of that baseline, effectively doubling the value of individual donations until the $200,000 limit is reached or the December 31, 2026 deadline passes, whichever comes first.

The structure matters for donors weighing a gift. A $100 contribution funds $200 of research under the match, and the campaign ties individual giving to an institution with a two-decade track record of directing industry money into peer-reviewed studies.

What comes next

The matching window runs for more than a year, giving veterinary teams, breed clubs and client communities time to organize fundraising around the deadline. As the funded studies mature — particularly the AI-based blood screening work — clinicians may gain tools that shift cancer detection in dogs and cats from late-stage presentation toward earlier, more treatable intervention.

Original: bluebuffalo.com

Share this article:

Nathan Brooks

Show full bio

Senior reporter covering companies, deals and strategy in Small- and large-animal clinical practice at The Vet Scope.

More from Nathan Brooks →